IRhythm Inks $45M Deal With Investors In Heart Device Suit
By Gina Kim · June 5, 2026, 7:08 PM EDT
IRhythm Technologies Inc. investors asked a California federal judge to preliminarily greenlight a $45 million settlement resolving allegations the digital healthcare company inflated stock prices with misrepresentations about its heart-event monitoring...
To view the full article, register now.